相关实验视频

Updated: Sep 11, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

用于增强黑色素瘤免疫治疗的刺激响应药物输送系统

Guoqing Zhang^1,2, Xiaojuan Zhang¹, Qiuxiang Dong³

¹Department of Pharmaceutics, Jiaxing Key Laboratory for Photonanomedicine and Experimental Therapeutics, College of Medicine, Jiaxing University, Jiaxing, 314001, People's Republic of China.

Drug design, development and therapy

|August 12, 2025

概括

刺激响应药物递送系统 (DDS) 利用黑色素瘤瘤微环境 (TME) 的特征来提高免疫治疗的有效性. 这些DDS为克服当前黑色素瘤治疗的局限性提供了一个有希望的战略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
生物医学工程生物医学工程

背景情况:

黑色素瘤是最致命的皮肤癌,尽管免疫疗法取得了进展,但死亡率很高.
黑色素瘤免疫治疗的局限性包括患者反应率低和副作用.
免疫抑制性瘤微环境 (iTME) 和瘤异质性阻碍了有效的治疗.

研究的目的:

澄清刺激响应药物递送系统 (DDS) 如何增强黑色素瘤免疫疗法.
为指导DDS作为黑色素瘤治疗剂的使用.
审查这些DDS的分类,设计和免疫增强途径.

主要方法:

对针对黑色素瘤而设计的刺激响应药物递送系统 (DDS) 的审查.
分析DDS如何利用瘤微环境 (TME) 的特征 (酸性,缺氧,蛋白酶).
检查黑色素瘤中DDSs激活的免疫增强途径.

主要成果:

对刺激有反应的DDS可以设计为针对特定的TME特征.
这些DDS可以调节免疫抑制TME以改善免疫细胞功能.
利用TME特征提供了一种增强抗瘤免疫反应的策略.

结论:

刺激反应型DDS是改善黑色素瘤免疫疗法的有效性的一种有希望的方法.
对DDS设计和免疫增强途径的进一步研究至关重要.
应对挑战和探索未来前景将优化DDS在黑色素瘤治疗中的应用.

关键词:

免疫疗法免疫疗法恶性黑色素瘤是一种恶性黑色素瘤.纳米颗粒是一种纳米粒子.刺激-响应的刺激.

更多相关视频

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Using In Vitro Live-cell Imaging to Explore Chemotherapeutics Delivered by Lipid-based Nanoparticles

Published on: November 1, 2017

A Melanoma Patient-Derived Xenograft Model

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.